• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Utility of major basic protein, eotaxin-3, and mast cell tryptase staining for prediction of response to topical steroid treatment in eosinophilic esophagitis: analysis of a randomized, double-blind, double dummy clinical trial.主要碱性蛋白、嗜酸性粒细胞趋化因子-3 和肥大细胞胰蛋白酶染色在预测嗜酸性粒细胞性食管炎对局部皮质类固醇治疗反应中的效用:一项随机、双盲、双模拟临床试验分析。
Dis Esophagus. 2020 Jun 15;33(6). doi: 10.1093/dote/doaa003.
2
Predictors of response to steroid therapy for eosinophilic esophagitis and treatment of steroid-refractory patients.嗜酸性食管炎对类固醇治疗反应的预测因素及类固醇难治性患者的治疗
Clin Gastroenterol Hepatol. 2015 Mar;13(3):452-8. doi: 10.1016/j.cgh.2014.07.034. Epub 2014 Jul 30.
3
Markers of eosinophilic inflammation for diagnosis of eosinophilic esophagitis and proton pump inhibitor-responsive esophageal eosinophilia: a prospective study.用于诊断嗜酸性粒细胞性食管炎和质子泵抑制剂反应性食管嗜酸性粒细胞增多症的嗜酸性粒细胞炎症标志物:一项前瞻性研究。
Clin Gastroenterol Hepatol. 2014 Dec;12(12):2015-22. doi: 10.1016/j.cgh.2014.06.019. Epub 2014 Jun 30.
4
Diagnostic utility of major basic protein, eotaxin-3, and leukotriene enzyme staining in eosinophilic esophagitis.主要碱性蛋白、嗜酸性粒细胞趋化因子-3 和白三烯酶染色在嗜酸性粒细胞性食管炎中的诊断价值。
Am J Gastroenterol. 2012 Oct;107(10):1503-11. doi: 10.1038/ajg.2012.202. Epub 2012 Jul 10.
5
Tryptase staining of mast cells may differentiate eosinophilic esophagitis from gastroesophageal reflux disease.肥大细胞的类胰蛋白酶染色可将嗜酸性粒细胞性食管炎与胃食管反流病区分开来。
Am J Gastroenterol. 2011 Feb;106(2):264-71. doi: 10.1038/ajg.2010.412. Epub 2010 Oct 26.
6
Clinical and Molecular Factors Associated With Histologic Response to Topical Steroid Treatment in Patients With Eosinophilic Esophagitis.与嗜酸性粒细胞性食管炎患者局部类固醇治疗组织学反应相关的临床和分子因素。
Clin Gastroenterol Hepatol. 2019 May;17(6):1081-1088.e2. doi: 10.1016/j.cgh.2018.09.005. Epub 2018 Sep 10.
7
Pre-treatment differential correlation of gene expression and response to topical steroids in eosinophilic esophagitis.嗜酸细胞性食管炎中外用皮质类固醇治疗反应与基因表达的预处理差异相关性。
Dis Esophagus. 2023 Mar 30;36(4). doi: 10.1093/dote/doac071.
8
Efficacy of Budesonide vs Fluticasone for Initial Treatment of Eosinophilic Esophagitis in a Randomized Controlled Trial.布地奈德与氟替卡松治疗嗜酸细胞性食管炎的随机对照试验。
Gastroenterology. 2019 Jul;157(1):65-73.e5. doi: 10.1053/j.gastro.2019.03.014. Epub 2019 Mar 11.
9
Rapid Recurrence of Eosinophilic Esophagitis Activity After Successful Treatment in the Observation Phase of a Randomized, Double-Blind, Double-Dummy Trial.随机、双盲、双模拟试验观察期成功治疗后嗜酸性食管炎活动的快速复发。
Clin Gastroenterol Hepatol. 2020 Jun;18(7):1483-1492.e2. doi: 10.1016/j.cgh.2019.08.050. Epub 2019 Sep 6.
10
Increased numbers of eosinophils, rather than only etiology, predict histologic changes in patients with esophageal eosinophilia.嗜酸性粒细胞增多而非仅仅病因可预测食管嗜酸性粒细胞增多患者的组织学变化。
Clin Gastroenterol Hepatol. 2012 Jul;10(7):735-41. doi: 10.1016/j.cgh.2012.01.008. Epub 2012 Jan 28.

引用本文的文献

1
Noninvasive Disease Assessment in Eosinophilic Esophagitis With Fractionated Exhaled Nitric Oxide, Blood, and Fecal Biomarkers.嗜酸性食管炎的无创疾病评估:呼出气一氧化氮、血液和粪便生物标志物分析
J Clin Gastroenterol. 2025 Sep 1;59(8):725-736. doi: 10.1097/MCG.0000000000002068.
2
Proton pump inhibitor effect on esophageal protein signature of eosinophilic esophagitis, prediction, and evaluation of treatment response.质子泵抑制剂对嗜酸性食管炎食管蛋白质特征、治疗反应预测及评估的影响。
Allergy. 2024 Dec;79(12):3448-3463. doi: 10.1111/all.16261. Epub 2024 Aug 2.
3
Expression of inducible nitric oxide synthase, nitrotyrosine, eosinophilic peroxidase, eotaxin-3, and galectin-3 in patients with gastroesophageal reflux disease, eosinophilic esophagitis, and in healthy controls: a semiquantitative image analysis of 3,3'-diaminobenzidine-stained esophageal biopsies.诱导型一氧化氮合酶、硝基酪氨酸、嗜酸性粒细胞过氧化物酶、嗜酸性粒细胞趋化因子-3 和半乳糖凝集素-3 在胃食管反流病、嗜酸性粒细胞性食管炎患者和健康对照者中的表达:3,3'-二氨基联苯胺染色食管活检的半定量图像分析。
Dis Esophagus. 2024 Aug 29;37(9). doi: 10.1093/dote/doae034.
4
Minimally Invasive Approaches to Diagnose and Monitor Eosinophilic GI Diseases.微创方法诊断和监测嗜酸性粒细胞性胃肠道疾病。
Curr Allergy Asthma Rep. 2024 May;24(5):269-279. doi: 10.1007/s11882-024-01142-0. Epub 2024 Mar 27.
5
Non-Invasive and Minimally Invasive Biomarkers for the Management of Eosinophilic Esophagitis beyond Peak Eosinophil Counts: Filling the Gap in Clinical Practice.嗜酸性粒细胞计数峰值之外用于管理嗜酸性食管炎的非侵入性和微创生物标志物:填补临床实践中的空白
Diagnostics (Basel). 2023 Aug 30;13(17):2806. doi: 10.3390/diagnostics13172806.
6
Mast Cell Esophagitis: A Novel Entity in Patients with Unexplained Esophageal Symptoms.肥大细胞性食管炎:不明原因食管症状患者的一种新实体。
Dysphagia. 2024 Jun;39(3):360-368. doi: 10.1007/s00455-023-10616-8. Epub 2023 Aug 21.
7
Medical treatment of eosinophilic esophagitis.嗜酸粒细胞性食管炎的治疗。
Cochrane Database Syst Rev. 2023 Jul 20;7(7):CD004065. doi: 10.1002/14651858.CD004065.pub4.
8
Validation of Epigenetic Markers for the Prediction of Response to Topical Corticosteroid Treatment in Eosinophilic Esophagitis.验证用于预测嗜酸性粒细胞性食管炎对外用皮质类固醇治疗反应的表观遗传标记物。
Clin Transl Gastroenterol. 2023 Sep 1;14(9):e00622. doi: 10.14309/ctg.0000000000000622.
9
A Newly Proposed Severity Index for Eosinophilic Esophagitis is Associated With Baseline Clinical Features and Successful Treatment Response.一项新提出的嗜酸性食管炎严重程度指数与基线临床特征和成功治疗反应相关。
Clin Gastroenterol Hepatol. 2023 Sep;21(10):2534-2542.e1. doi: 10.1016/j.cgh.2023.03.047. Epub 2023 Apr 14.
10
Pre-treatment differential correlation of gene expression and response to topical steroids in eosinophilic esophagitis.嗜酸细胞性食管炎中外用皮质类固醇治疗反应与基因表达的预处理差异相关性。
Dis Esophagus. 2023 Mar 30;36(4). doi: 10.1093/dote/doac071.

本文引用的文献

1
Efficacy of Dupilumab in a Phase 2 Randomized Trial of Adults With Active Eosinophilic Esophagitis.度普利尤单抗在成人活性嗜酸性粒细胞性食管炎的 2 期随机试验中的疗效。
Gastroenterology. 2020 Jan;158(1):111-122.e10. doi: 10.1053/j.gastro.2019.09.042. Epub 2019 Oct 5.
2
Rapid Recurrence of Eosinophilic Esophagitis Activity After Successful Treatment in the Observation Phase of a Randomized, Double-Blind, Double-Dummy Trial.随机、双盲、双模拟试验观察期成功治疗后嗜酸性食管炎活动的快速复发。
Clin Gastroenterol Hepatol. 2020 Jun;18(7):1483-1492.e2. doi: 10.1016/j.cgh.2019.08.050. Epub 2019 Sep 6.
3
Pharmacotherapies for the Treatment of Eosinophilic Esophagitis: State of the Art Review.嗜酸粒细胞性食管炎的药物治疗:最新综述。
Drugs. 2019 Sep;79(13):1419-1434. doi: 10.1007/s40265-019-01173-2.
4
Efficacy of Budesonide Orodispersible Tablets as Induction Therapy for Eosinophilic Esophagitis in a Randomized Placebo-Controlled Trial.布地奈德口腔崩解片作为嗜酸细胞性食管炎诱导治疗的疗效:一项随机安慰剂对照试验。
Gastroenterology. 2019 Jul;157(1):74-86.e15. doi: 10.1053/j.gastro.2019.03.025. Epub 2019 Mar 26.
5
Efficacy of Budesonide vs Fluticasone for Initial Treatment of Eosinophilic Esophagitis in a Randomized Controlled Trial.布地奈德与氟替卡松治疗嗜酸细胞性食管炎的随机对照试验。
Gastroenterology. 2019 Jul;157(1):65-73.e5. doi: 10.1053/j.gastro.2019.03.014. Epub 2019 Mar 11.
6
A Conceptual Approach to Understanding Treatment Response in Eosinophilic Esophagitis.理解嗜酸性粒细胞性食管炎治疗反应的概念方法。
Clin Gastroenterol Hepatol. 2019 Oct;17(11):2149-2160. doi: 10.1016/j.cgh.2019.01.030. Epub 2019 Jan 30.
7
RPC4046, a Monoclonal Antibody Against IL13, Reduces Histologic and Endoscopic Activity in Patients With Eosinophilic Esophagitis.RPC4046,一种针对 IL13 的单克隆抗体,可降低嗜酸性食管炎患者的组织学和内镜活动。
Gastroenterology. 2019 Feb;156(3):592-603.e10. doi: 10.1053/j.gastro.2018.10.051. Epub 2018 Nov 2.
8
Clinical and Molecular Factors Associated With Histologic Response to Topical Steroid Treatment in Patients With Eosinophilic Esophagitis.与嗜酸性粒细胞性食管炎患者局部类固醇治疗组织学反应相关的临床和分子因素。
Clin Gastroenterol Hepatol. 2019 May;17(6):1081-1088.e2. doi: 10.1016/j.cgh.2018.09.005. Epub 2018 Sep 10.
9
Updated International Consensus Diagnostic Criteria for Eosinophilic Esophagitis: Proceedings of the AGREE Conference.更新的嗜酸性粒细胞性食管炎国际共识诊断标准:AGREE 会议纪要。
Gastroenterology. 2018 Oct;155(4):1022-1033.e10. doi: 10.1053/j.gastro.2018.07.009. Epub 2018 Sep 6.
10
Association of mast cells with clinical, endoscopic, and histologic findings in adults with eosinophilic esophagitis.肥大细胞与成人嗜酸性粒细胞性食管炎临床、内镜及组织学表现的相关性
Allergy. 2018 Oct;73(10):2088-2092. doi: 10.1111/all.13530. Epub 2018 Jul 13.

主要碱性蛋白、嗜酸性粒细胞趋化因子-3 和肥大细胞胰蛋白酶染色在预测嗜酸性粒细胞性食管炎对局部皮质类固醇治疗反应中的效用:一项随机、双盲、双模拟临床试验分析。

Utility of major basic protein, eotaxin-3, and mast cell tryptase staining for prediction of response to topical steroid treatment in eosinophilic esophagitis: analysis of a randomized, double-blind, double dummy clinical trial.

机构信息

Center for Esophageal Diseases and Swallowing, and Center for Gastrointestinal Biology and Disease, Division of Gastroenterology and Hepatology, University of North Carolina School of Medicine, Chapel Hill, NC, USA.

Department of Pathology and Laboratory Medicine; University of North Carolina School of Medicine, Chapel Hill, NC, USA.

出版信息

Dis Esophagus. 2020 Jun 15;33(6). doi: 10.1093/dote/doaa003.

DOI:10.1093/dote/doaa003
PMID:32193541
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7273184/
Abstract

Inflammatory factors in eosinophilic esophagitis (EoE), including major basic protein (MBP), eotaxin-3 (EOT3) and mast cell tryptase (TRP), may predict treatment response to topical corticosteroids (tCS). We aimed to determine whether baseline levels of these markers predict response to tCS for EoE. To do this, we analyzed data from a randomized trial comparing two topical steroids for treatment of newly diagnosed EoE (NCT02019758). A pretreatment esophageal biopsy was stained for MBP, EOT3, and TRP to quantify tissue biomarker levels (cells/mm2). Levels were compared between histologic responders (<15 eos/hpf) and nonresponders (the primary outcome), and endoscopic responders (EREFS<2) and nonresponders. Complete histologic response (<1 eos/hpf) was also assessed, and area under the receiver operator characteristic curve (AUC) was calculated. We also evaluated whether baseline staining predicted symptom relapse in the trial's off-treatment observation phase. Baseline samples were evaluable in 110/111 subjects who completed the randomized trial. MBP levels were higher in nonresponders (n = 36) than responders (704 vs. 373 cells/mm2; P = 0.007), but EOT3 and TRP levels were not statistically different. The combination of all three stains had an AUC of 0.66 to predict response. For complete histologic response, baseline TRP levels were higher in nonresponders (n = 69) than responders (370 vs. 268 mast cells/mm2; P = 0.01), with an AUC of 0.65. The AUC for endoscopic response was 0.68. Baseline staining did not predict symptom recurrence after remission. Pretreatment MBP, EOT3, and TRP levels were not strongly or consistently associated with histologic or endoscopic response to topical steroids. While elevated TRP levels may be associated with nonresponse compared with complete response, the magnitude and predictive utilities were modest. Novel methods for predicting steroid response are still required.

摘要

嗜酸性食管炎(EoE)中的炎症因子,包括主要碱性蛋白(MBP)、嗜酸性粒细胞趋化因子-3(EOT3)和肥大细胞胰蛋白酶(TRP),可能预测局部皮质类固醇(tCS)治疗的反应。我们旨在确定这些标志物的基线水平是否可预测 EoE 对 tCS 的反应。为此,我们分析了一项比较两种局部皮质类固醇治疗新诊断的 EoE 的随机试验的数据(NCT02019758)。在治疗前进行食管活检,对 MBP、EOT3 和 TRP 进行染色以定量组织生物标志物水平(细胞/mm2)。比较组织学应答者(<15 个 eos/hpf)和无应答者(主要结局)、内镜应答者(EREFS<2)和无应答者之间的水平。还评估了完全组织学应答(<1 eos/hpf),并计算了接收者操作特征曲线(ROC)下的面积(AUC)。我们还评估了基线染色是否预测试验停药观察期的症状复发。在完成随机试验的 111 名受试者中,有 110 名可评估基线样本。无应答者(n = 36)的 MBP 水平高于应答者(704 与 373 细胞/mm2;P = 0.007),但 EOT3 和 TRP 水平无统计学差异。所有三种染色的组合预测反应的 AUC 为 0.66。对于完全组织学应答,无应答者(n = 69)的基线 TRP 水平高于应答者(370 与 268 肥大细胞/mm2;P = 0.01),AUC 为 0.65。内镜反应的 AUC 为 0.68。基线染色不能预测缓解后症状复发。治疗前 MBP、EOT3 和 TRP 水平与局部皮质类固醇的组织学或内镜反应无强关联或一致性关联。虽然与完全应答相比,升高的 TRP 水平可能与无应答相关,但幅度和预测效用较小。仍需要新的方法来预测类固醇反应。